ArticleFrontiers in oncology2019

ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1.

Ferdinando Maria Milazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.